Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2010-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trabeculectomy Versus Canaloplasty to Treat Glaucoma
NCT00854256
Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma
NCT00917670
GATT Versus Canaloplasty (GVC)
NCT05366647
Phaco-Trabeculotomy Vs Phaco-Trabeculectomy
NCT04683055
SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients
NCT07152132
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trabeculectomy
Trabeculectomy with Mitomycin C
trabeculectomy
trabeculectomy with mitomycin C 0.2mg/ml
Canaloplasty
Canaloplasty with implant of suture
Canaloplasty
Canaloplasty with implant of suture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
trabeculectomy
trabeculectomy with mitomycin C 0.2mg/ml
Canaloplasty
Canaloplasty with implant of suture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
2. congenital glaucoma
3. combined procedures (glaucoma and cataract)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Eye Hospital, Würzburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospitals Würzburg
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Klink, MD
Role: PRINCIPAL_INVESTIGATOR
University Eye Hospital, Würzburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Eye Hospital
Würzburg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TVC
Identifier Type: OTHER
Identifier Source: secondary_id
TVC-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.